We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Invitae

News List

Biogen and Invitae to Offer Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients americanpharmaceuticalreview
August 21, 2019
Biogen Inc. and Invitae Corporation have announced that SMA STAT, a new, rapid-turnaround genetic test for spinal muscular atrophy (SMA), will be offered at no charge to individuals in the U.S. as part of the SMA Identified program.
Sarepta taps Invitae to identify participants for DMD trials fiercebiotech
May 08, 2018
Sarepta Therapeutics has partnered with genetic testing company Invitae to identify participants for its Duchenne muscular dystrophy (DMD) clinical trials. The initiative taps into the networks Invitae ...